TherapeuticsMD, Inc. — Director's Dealing 2020

Jun 8, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TherapeuticsMD, Inc. (TXMD)
CIK: 0000025743
Period of Report: 2020-06-04

Reporting Person: Thompson Tommy G (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-06-04	Common Stock	P	8700	$1.13	Acquired	699600	Indirect

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1001	Indirect
Common Stock	3555	Direct

Footnotes

F1: The reported securities are owned by Thompson Family Investments, LLC, an entity solely owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.

F2: The reported securities are owned by Thompson Family Holdings, LLC, an entity solely owned by Mr. Thompson.